MDCX
MDCX
NASDAQ · Biotechnology

Medicus Pharma Ltd

$1.11
+0.02 (+1.83%)
As of Feb 8, 2:23 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.30M 4.98M 4.38M
Net Income -11,481 -9,902 -8,948
EPS
Profit Margin -0.2% -0.2% -0.2%
Rev Growth +3.9% +11.7% +7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.67M 8.33M 6.88M
Total Equity 18.34M 20.50M 18.38M
D/E Ratio 0.42 0.41 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -10,930 -11,209 -8,630
Free Cash Flow -9,428 -11,072 -6,340